1. Proliferation marker Ki-67 in early breast cancer.
   Ian E. Smith et al, 2005, J. Clin. Oncol. CrossRef
2. Comparison of the Systemic and Intratumoral Effects of Tamoxifen and the Aromatase Inhibitor Vorozole in Postmenopausal Patients With Primary Breast Cancer
   Catherine L. Harper-Wynne et al, 2002, JCO CrossRef